ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway. Xu S, Zhu C, Xu Q, An Z, et al. Int J Oncol 2024;65:76.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu S, Zhu C, Xu Q, An Z, et al. ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway. Int J Oncol 2024;65:76.
PMID: 38873993